Management of Fragments During Ureteroscopy
Should we Strive for Absolute "Stone Freedom" While Performing Holmium Laser Lithotripsy for Ureteral Stones? A Randomized Controlled Trial.
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to study the outcome of patients after ureteroscopy in which all fragments remaining after holmium laser lithotripsy were retrieved compared to those where small, insignificant fragments were left for spontaneous passage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
March 12, 2008
CompletedFirst Posted
Study publicly available on registry
March 18, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2008
CompletedFebruary 10, 2009
February 1, 2009
10 months
March 12, 2008
February 9, 2009
Conditions
Outcome Measures
Primary Outcomes (1)
unplanned medical visits
30 days
Secondary Outcomes (1)
Hospital Admissions, need for pain killers, time to complete recovery
60 days
Study Arms (2)
B
EXPERIMENTALExperimental group: patients in whom "stone dust" was left for spontaneous elimination
A
OTHERControl group: Patients in whom all fragments resulting from laser lithotripsy of ureteral stones were actively retrieved
Interventions
Eligibility Criteria
You may qualify if:
- Patient with ureteral stones suitable for endoscopic treatment
You may not qualify if:
- presence of ipsilateral kidney stones
- known ureteral stricture
- previous placement of ureteral stent
- use of drugs with known activity on smooth ureteral muscle
- unwillingness or impossibility to return for follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Chaim Sheba Medical Center
Tel Litwinsky, Ramat Gan, 52621, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 12, 2008
First Posted
March 18, 2008
Study Start
June 1, 2007
Primary Completion
April 1, 2008
Study Completion
May 1, 2008
Last Updated
February 10, 2009
Record last verified: 2009-02